GB/T 16886.5-2003
AbolishedBiological evaluation ofmedical devices--Part 5: Test for in vitro cytotoxicity
医疗器械生物学评价 第5部分: 体外细胞毒性试验
Application Summary AI generated
This standard specifies test methods to evaluate the in vitro cytotoxic potential of medical device materials and extracts using cell culture techniques. It is applied during the biological safety assessment of medical devices, such as implants, surgical instruments, and drug delivery systems, to determine if leachable substances cause cell death or growth inhibition. The standard is used by manufacturers and testing laboratories to screen materials for biocompatibility before clinical use.
Related Standards
GB/T 19381-2003
General methods of test for medical closures of butyl rubber
GB/T 14214-2003
Spectacle frames--General requirements and test methods
GB/T 18375.5-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 5:Supplementary structural tests
GB/T 18375.6-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 6:Loading parameters of supplementary structural tests
GB/T 18375.7-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 7:Test submission document
GB/T 18375.8-2004
Prosthetics--Structural testing of lower-limb prostheses--Part 8:Test report
GB/T 19543-2004
Prostheses--Structural testing of hip units
GB/T 19629-2005
Medical Electrical Equipment-Dosimeters with ionization chambers and/or semi-conductors as used in X-ray diagnostic imaging
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.